For the second time in the past 6 months, a cardiology mainstay drug has lost patent protection and gone generic. Today, the FDA announced that it had approved several generic versions of clopidogrel (Plavix), the antiplatelet drug that for many years was the second best-selling drug in the world. Last November, the best-selling drug of all time,…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: antiplatelets, Brilinta, clopidogrel, Effient, generics, Plavix, prasugrel, ticagrelor
- 0 Recommendations
- |
- 1 Comment
A very large meta-analysis provides strong evidence that the relative reduction in vascular risk with statins is at least as great in low-risk patients as in high-risk patients. The finding, write the authors, provides evidence that expansion of guidelines to lower-risk populations should be considered. In their paper in the Lancet, the Cholesterol Treatment Trialists’ (CTT)…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: LDL cholesterol, statins
- 0 Recommendations
- |
- 0 Comments
A genetics-based analysis finds that raising HDL will not necessarily lower risk for myocardial infarction. Reporting in the Lancet, researchers describe a two-pronged approach. First, they searched for the presence of a specific allele (LIPG Asn396Ser, associated with higher HDL levels in carriers) in a large cohort of subjects with and without MI. The allele’s…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: cholesterol, HDL, LDL
- 0 Recommendations
- |
- 2 Comments
The antibiotic azithromycin — which may have proarrhythmic properties — is associated with increased risk for cardiovascular death, according to a retrospective cohort study in the New England Journal of Medicine. The study, in a Medicaid population, included nearly 350,000 azithromycin prescriptions, 1.4 million control periods without antibiotic prescriptions, and 1.8 million prescriptions for other…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: antibiotics, azithromycin
- 0 Recommendations
- |
- 0 Comments
Reductions in air pollution during the Beijing Olympics were associated with decreases in certain biomarkers of inflammation and thrombosis in healthy young adults, according to a JAMA study. Researchers measured levels of air pollutants in 2-week periods before, during, and after the Olympics, and also measured blood levels of cardiovascular disease biomarkers in 125 healthy…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: air pollution, biomarkers
- 0 Recommendations
- |
- 1 Comment
Routine exercise echocardiography in asymptomatic patients after revascularization does not lead to better outcomes, according to a new study published in Archives of Internal Medicine. Although guidelines generally discourage the practice, post-revascularization stress tests are still commonly performed. Serge Harb and colleagues performed exercise echocardiography on 2105 patients after CABG surgery or PCI and followed…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: CABG, exercise echocardiography, PCI, revascularization, stress testing
- 0 Recommendations
- |
- 0 Comments
The biggest drawback to drug-eluting stents has been the requirement for prolonged dual antiplatelet (DAPT) therapy following stent implantation to prevent stent thrombosis and other potential complications. The precise length of DAPT has been the subject of considerable discussion and research. Now the Xience Prime and Xience V everolimus-eluting stents have received the CE Mark…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: DAPT, drug-eluting stents, dual antiplatelet therapy, Xience
- 0 Recommendations
- |
- 1 Comment
A large study looking at real-world use of elective coronary artery bypass surgery (CABG) and stenting (PCI) in New York State finds that nearly two thirds of PCI procedures have inappropriate or uncertain indications. By contrast, 90% of CABG procedures were deemed appropriate and 1.1% inappropriate. In a paper published in the Journal of the American…
This content is exclusive to CardioExchange. To continue reading, please log in or request an invitation.
Tags: appropriate use criteria, CABG, New York State, PCI, revascularization
- 0 Recommendations
- |
- 1 Comment